Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report

Metastatic uveal melanoma (UM) is a rare form of melanoma differing from cutaneous melanoma by etiology, prognosis, driver mutations, pattern of metastases and poor response rate to immune checkpoint inhibitors (ICI). Recently, a bispecific gp100 peptide-HLA-directed CD3 T cell engager, tebentafusp,...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiter, Selina, Schroeder, Christopher, Broche, Julian, Sinnberg, Tobias, Bonzheim, Irina, Süsskind, Daniela, Flatz, Lukas, Forschner, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189013/
https://www.ncbi.nlm.nih.gov/pubmed/37207136
http://dx.doi.org/10.3389/fonc.2023.1167791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189013/
https://www.ncbi.nlm.nih.gov/pubmed/37207136
http://dx.doi.org/10.3389/fonc.2023.1167791

Ejemplares similares